日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Distinct Tumor-Immune Ecologies in Patients with Lung Cancer Predict Progression and Define a Clinical Biomarker of Therapy Response

肺癌患者中不同的肿瘤免疫生态可预测疾病进展并确定治疗反应的临床生物标志物。

Prabhakaran, Sandhya; Gatenbee, Chandler D; Robertson-Tessi, Mark; Gahramanli Ozturk, Zarifa; Boyle, Theresa A; Gray, Jhanelle E; Antonia, Scott J; Gatenby, Robert A; Beg, Amer A; Anderson, Alexander R A

Evolutionary Double-Bind Treatment Using Radiation Therapy and Natural Killer Cell-Based Immunotherapy in Prostate Cancer

前列腺癌放射疗法与自然杀伤细胞免疫疗法相结合的进化双靶点治疗

Luddy, Kimberly A; West, Jeffrey; Robertson-Tessi, Mark; Desai, Bina; Ojeda, Andrew; Newman, Hannah; Estrella, Veronica; Bursell, Taylor M; Barrett, Sarah; O'Sullivan, Jacintha; Marignol, Laure; Gatenby, Robert A; Brown, Joel S; Anderson, Alexander R A; O'Farrelly, Cliona

The future of mathematical oncology in the age of AI

人工智能时代数学肿瘤学的未来

Rockne, Russell C; Andersen, Morten; Anderson, Alexander R A; Basanta, David; Bentivegna, Angela; Benzekry, Sebastien; Branciamore, Sergio; Brüningk, Sarah C; Conte, Martina; Farahpour, Farnoush; Karolak, Aleksandra; Köhn-Luque, Alvaro; Lorenzo, Guillermo; Manookian, Babgen; Rodin, Andrei S; Schmalenstroer, Lara; Soler, Juan; Tomasetti, Cristian; Urbaniak, Konstancja

75 Years of Mathematical Oncology

数学肿瘤学75周年

Pradelli, Franco; Strobl, Maximilian; Marzban, Sadegh; de Kermenguy, François; Barnett, Ari; Ganesan, Katyayni; Lorenzo, Guillermo; Hormuth, David A 2nd; Hamis, Sara; Bhaskar, Dhananjay; Anderson, Alexander R A; West, Jeffrey

Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial.

纳武利尤单抗溶瘤免疫疗法治疗肌层浸润性膀胱癌:一项 1b 期试验

Li Roger, Villa Nancy Y, Yu Xiaoqing, Johnson Joseph O, Borjas Gustavo, Dhillon Jasreman, Moran-Segura Carlos M, Kim Youngchul, Francis Natasha, Dorman Denise, Powers John J, Sexton Wade J, Spiess Philippe E, Poch Michael A, Zemp Logan, Gilbert Scott M, Zhang Jingsong, Pow-Sang Julio M, Anderson Alexander R A, Li Tingyi, Wang Xuefeng, Grass G Daniel, Burke James M, Dinney Colin P N, Rodriguez Paulo C, Jain Rohit K, Mulé James J, Conejo-Garcia Jose R

Mathematical Oncology: How Modeling Is Transforming Clinical Decision-Making

数学肿瘤学:建模如何改变临床决策

Scibilia, Kevin R; Gallagher, Kit; Masud, M A; Robertson-Tessi, Mark; Gatenbee, Chandler D; West, Jeffrey; Llamas, Paul; Prabhakaran, Sandhya; Gallaher, Jill; Anderson, Alexander R A

The role of environmentally mediated drug resistance in facilitating the spatial distribution of residual disease

环境介导的耐药性在促进残留疾病的空间分布中的作用

Milne, Amy; Marusyk, Andriy; Maini, Philip K; Anderson, Alexander R A; Picco, Noemi

Deriving Optimal Treatment Timing for Adaptive Therapy: Matching the Model to the Tumor Dynamics

确定自适应治疗的最佳治疗时机:使模型与肿瘤动力学相匹配

Gallagher, Kit; Strobl, Maximilian A R; Anderson, Alexander R A; Maini, Philip K

PSA/testosterone ratio as a potential biomarker to identify early progressors of adaptive therapy in metastatic castration sensitive prostate cancer

PSA/睾酮比值作为识别转移性去势敏感性前列腺癌早期适应性治疗进展者的潜在生物标志物

Gallaher, Jill A; Gatenby, Robert A; Brown, Joel S; Anderson, Alexander R A; Zhang, Jingsong

Evolutionary antifragile therapy

进化反脆弱疗法

West, Jeffrey; Desai, Bina; Strobl, Maximilian; Gallaher, Jill; Robertson-Tessi, Mark; Marusyk, Andriy; Anderson, Alexander R A